Development of wireless multi-parameter monitoring system for viruses and very slow growing microorganisms
Biophage Pharma signs collaborates with National Taiwan University
Biophage Pharma and the Institute of Biomedical Engineering of the NTU (National Taiwan University) announced the signing of a collaborative agreement aimed at accelerating the development and applications of novel nanotechnology-based biosensors for the detection of slow growing microorganisms and viruses.
Combining the unique properties of Surface Plasmon Resonance (SPR), gold nanoparticles and phages (or antibodies), this wireless multi-parameter monitoring system will be mainly used for the detection and quantification of viruses and very slow growing microorganisms like Mycobacterium tuberculosis.
Established in 1928, the National Taiwan University is the most prestigious and first integrated institution of higher education in Taiwan. "We are very proud to work with such a prestigious university and a high profile team. This M.O.U. marks a new and very exciting development in our portfolio of products extending our capabilities and adding a novel element to our detection products", said Dr. Mandeville, President and Chief Executive Officer. "The detection of very slowly growing bacteria such as Mycobacterium (7 to 10 days for tuberculosis) and also viruses are presently difficult with our impedance-based biosensor. The use of SPR and phages (or antibodies) will solved this difficulty and is, therefore, a perfect fit with the portfolio of products we are developing", added Dr. Mandeville.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous